Financials

  • Market Capitalization 415.69 M
  • Employee 200
  • Founded 2015
  • CEO N/A
  • Website www.ars-pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00FZQGXG3
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.7
Relación precio/flujo de caja
13.63

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2955
PRTA
Prothena Corporation plc - Ordinary Shares
8.43 USD-4.64%+1.81%-5.81%-18.31%432.77 M USD
2977
EDIT
Editas Medicine, Inc. - Common Stock
2.75 USD-5.17%-3.51%+2.23%-20.06%422.35 M USD
2990
DRUG
Bright Minds Biosciences Inc. - common stock
54.01 USD-0.07%+8.21%-14.04%-14.27%412.41 M USD
3002
AVIR
Atea Pharmaceuticals, Inc. - common stock
5.03 USD-2.33%-2.52%-5.27%+56.70%403.43 M USD

Noticias